• Bausch + Lomb flagged new clinical study data for presentation at the AAO annual meeting in New Orleans on Oct. 9-12.
• Posters cover cataract and glaucoma procedures, including outcomes that suggest stable vision with fewer medications following a MIGS approach.
• Additional studies assess premium intraocular lenses, with real-world results focused on visual and refractive performance in routine practice.
• Dry-eye research highlights provider-identified responder profiles for Xiidra, with separate work evaluating Miebo use around contact lens wear.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.